Position in INCY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,342,409
+$762,630 QoQ
Shares Held
11,842
+92.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#383
of 854 holders
Holding Since
Mar 2025
3 quarters on record
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saudi Central Bank holds $22,821,239 across 7 Biotechnology names. INCY ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,805 | $8,844,277 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,273 | $4,535,006 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,284 | $2,794,762 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
11,324 | $2,120,758 | |
| 5 | RPRX |
Royalty Pharma plc
|
28,773 | $1,613,302 | |
| 6 | INSM |
INSMED Inc
|
14,732 | $1,570,725 | |
| 7 | INCY |
Incyte Corp
This page
|
11,842 | $1,342,409 |
All Filings in INCY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,342,409 | 11,842 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $579,779 | 6,160 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $3,875 | 64 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||